UNSPSC 51322503: Implitapide

This classification denotes an anti-lipidemic agent with the molecular formula C35H37N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q70OH404HR, chemically known as (alphas)-alpha-(alpha-(2,4-dimethyl-9h-pyrido(2,3-b)indol-9-yl)-p-tolyl)-n-((alphar)-alpha-(hydroxymethyl)benzyl)cyclopentaneacetamide. but generally known as implitapide, which bears US NIH Compound Identifier 5745206. The term IMPLITAPIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44).

UNSPSC 51322503 Implitapide is a Commodity code that state and local jurisdictions use to procure advanced life support medications and other pharmaceutical products for emergency medical services and healthcare delivery. The City of Tampa's recent bid for Advanced Life Support Medications illustrates the actual scope of work: supply of specific injectable medications such as Labetalol HCI, Epinephrine, Adenosine, and Diltiazem in defined unit quantities, with strict expiration-date requirements, rapid fulfillment timelines, and vendor accountability for product defects and material replacement. State and local buyers under this code include municipal fire departments and rescue services that operate their own EMS fleets or provide paramedic response, as well as county health agencies and hospital systems. Vendors must manage cold-chain compliance, safety documentation (Safety Data Sheets compliant with OSHA standards), and accessibility reporting (WCAG 2.2 and Section 508 conformance). The sourcing model typically favors lowest-responsive, responsible bidder under IFB or sealed-bid procedures, with firm pricing that includes freight and taxes.

The City of Tampa, Department of Purchasing, issued Bid No. 26P00188 on April 24, 2026, with a response deadline of April 8, 2026, seeking four lines of advanced life support medications for Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00. The solicitation offered a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation not to exceed $10,000 and a one-year contract term with options to renew for two additional one-year periods plus three unilateral 30-day extensions. Vendors were required to submit bids through the OpenGov eProcurement Portal and warranted all materials free from defects for a minimum of 365 days, with delivery required within ten calendar days of order receipt and all medications maintaining a nine-month minimum expiration date from acceptance.